Buserelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist used primarily to treat hormone-responsive conditions, including prostate cancer, endometriosis, and uterine fibroids, as well as… Read more



![Chemical structure of Buserelin EP Impurity D Ditrifluoroacetate ([5-D-Tyr]-Buserelin Ditrifluoroacetate)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FBuserelin-EP-Impurity-D-Ditrifluoroacetate-5-D-Tyr-Buserelin-Ditrifluoroacetate.png&w=3840&q=75)
![Chemical structure of Buserelin EP Impurity E Ditrifluoroacetate ([1-(5-oxo-D-Proline)]-Buserelin Ditrifluoroacetate)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FBuserelin-EP-Impurity-E-Ditrifluoroacetate-1-5-oxo-D-Proline-Buserelin-Ditrifluoroacetate.png&w=3840&q=75)


Buserelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist used primarily to treat hormone-responsive conditions, including prostate cancer, endometriosis, and uterine fibroids, as well as in assisted reproduction. Laboratories utilizing this peptide require high-quality reference standards to ensure the accuracy of their analytical testing and quality control procedures. Our selection includes the active pharmaceutical ingredient (API) alongside a range of related compounds, such as identified process-related and degradation impurities, to support comprehensive impurity profiling and method validation. For advanced quantitative analysis, particularly in complex biological matrices, we provide stable isotope-labelled compounds that function as internal standards. These materials are essential for verifying the selectivity and sensitivity of high-performance liquid chromatography and mass spectrometry methods during pharmaceutical development and rigorous regulatory testing.